ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000224271.1	Ponatinib	Bladder urothelial carcinoma	0.03735191	Resistant
ENSG00000224271.1	Ponatinib	Skin cutaneous melanoma	0.020942047	Sensitive